- Home
- CBT vs AGO Comparison
CBT vs AGO Comparison
Compare CBT & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBT
- AGO
- Stock Information
- Founded
- CBT 2019
- AGO 2003
- Country
- CBT United States
- AGO Bermuda
- Employees
- CBT N/A
- AGO N/A
- Industry
- CBT Major Chemicals
- AGO Property-Casualty Insurers
- Sector
- CBT Industrials
- AGO Finance
- Exchange
- CBT Nasdaq
- AGO Nasdaq
- Market Cap
- CBT 5.0B
- AGO 4.0B
- IPO Year
- CBT N/A
- AGO 2004
- Fundamental
- Price
- CBT $109.24
- AGO $91.25
- Analyst Decision
- CBT Hold
- AGO Buy
- Analyst Count
- CBT 4
- AGO 4
- Target Price
- CBT $105.00
- AGO $91.00
- AVG Volume (30 Days)
- CBT 443.3K
- AGO 273.7K
- Earning Date
- CBT 11-04-2024
- AGO 11-11-2024
- Dividend Yield
- CBT 1.58%
- AGO 1.37%
- EPS Growth
- CBT N/A
- AGO 73.00
- EPS
- CBT 6.72
- AGO 13.02
- Revenue
- CBT $3,994,000,000.00
- AGO $867,000,000.00
- Revenue This Year
- CBT $6.38
- AGO N/A
- Revenue Next Year
- CBT $3.60
- AGO N/A
- P/E Ratio
- CBT $16.24
- AGO $7.03
- Revenue Growth
- CBT 1.60
- AGO N/A
- 52 Week Low
- CBT $70.63
- AGO $65.39
- 52 Week High
- CBT $117.46
- AGO $96.60
- Technical
- Relative Strength Index (RSI)
- CBT 45.49
- AGO 61.17
- Support Level
- CBT $112.82
- AGO $88.85
- Resistance Level
- CBT $117.25
- AGO $95.52
- Average True Range (ATR)
- CBT 2.84
- AGO 2.01
- MACD
- CBT -0.24
- AGO 0.47
- Stochastic Oscillator
- CBT 38.20
- AGO 59.99
About CBT Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets, and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal and healthcare experience. The company is operating in two segments Insurance segment and the Asset Management segment. The majority of the revenue earned by the company from the Insurance segment.